Event Type
Disclosure
Voluntary
Variant
8-K
Other Events On June 17, 2025, IGC Pharma, Inc. (“IGC” or the “Company”) made available on its website an updated corporate presentation titled Clinical Study U
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Clinical Study Presentation dated June 17, 2025. 104 Cover Page Interactive Data Fil